Dynamic Neurocognitive Adaptation in aging: developing and validation of a new scale

Abstract Background Up to 40% of current AD cases may have been preventable through protective factors, such as physical and cognitive activities, preventing neurodegeneration. Reserve, resilience, and resistance are key concepts in cognitive neuroscience of aging, and they share common adaptive mechanisms. In this paper we propose a development and validation of a new scale, called dynamic Neurocognitive Adaptation (dNA). Method This study included 815 participants (50% women) with a minimum age of 65 years, divided in two subsamples: exploratory factor analysis (EFA), and confirmatory factor analysis (CFA). Data collection utilized survey measures administered via Qualtrics . Our initial scale was composed of 30 items, investigating 7 different dimensions, explored by a 5‐point Likert scale reflecting frequency of activities. We investigated lifetime through 7 time‐windows, from childhood (0‐10) to old age (65+). Result Our final scale is composed by 20 items divided among 4 dimensions (physical, cognitive, social, and creative). Scale assessment indicated that there were no issues found related to multi‐collinearity ( r < 0.95) or non‐collinearity ( r < 0.3). For the final model, KMO = .80 and Bartlett’s test of sphericity indicated all values ≤0.01. Our Cronbach’s alpha was .83. Conclusion We have validated a reliable, novel, easy to complete, and comprehensive scale to assess lifetime adaptive behaviors, which can be applied in research on AD risk reduction, MCI, and in clinical practice. We underlined the dynamic role of time and the investigation of the creative dimension in aging. Our dNA can be used to personalize health recommendations in aging.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.087584
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dynamic Neurocognitive Adaptation in aging: developing and validation of a new scale

Chad L. Cross, Filippo Cieri, Giulia Di Francesco, Andrew R. Bender et al.
1 links
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Dynamic Neurocognitive Adaptation in aging: developing and validation of a new scale

Chad L. Cross, Filippo Cieri, Giulia Di Francesco, Andrew R. Bender, Jessica ZK Caldwell
article en

Abstract

Abstract Background Up to 40% of current AD cases may have been preventable through protective factors, such as physical and cognitive activities, preventing neurodegeneration. Reserve, resilience, and resistance are key concepts in cognitive neuroscience of aging, and they share common adaptive mechanisms. In this paper we propose a development and validation of a new scale, called dynamic Neurocognitive Adaptation (dNA). Method This study included 815 participants (50% women) with a minimum age of 65 years, divided in two subsamples: exploratory factor analysis (EFA), and confirmatory factor analysis (CFA). Data collection utilized survey measures administered via Qualtrics . Our initial scale was composed of 30 items, investigating 7 different dimensions, explored by a 5‐point Likert scale reflecting frequency of activities. We investigated lifetime through 7 time‐windows, from childhood (0‐10) to old age (65+). Result Our final scale is composed by 20 items divided among 4 dimensions (physical, cognitive, social, and creative). Scale assessment indicated that there were no issues found related to multi‐collinearity ( r < 0.95) or non‐collinearity ( r < 0.3). For the final model, KMO = .80 and Bartlett’s test of sphericity indicated all values ≤0.01. Our Cronbach’s alpha was .83. Conclusion We have validated a reliable, novel, easy to complete, and comprehensive scale to assess lifetime adaptive behaviors, which can be applied in research on AD risk reduction, MCI, and in clinical practice. We underlined the dynamic role of time and the investigation of the creative dimension in aging. Our dNA can be used to personalize health recommendations in aging.

Alzheimer s & DementiaVol. 20(S4)
Cleveland Clinic (US), University of Nevada, Las Vegas (US), Lou Ruvo Brain Institute (US), Azienda USL di Pescara (IT)
Openalex Percentile: Top 65%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.